Yuan Zhi
Stock Analyst at B. Riley Securities
(2.10)
# 2,973
Out of 5,139 analysts
32
Total ratings
41.94%
Success rate
-1.35%
Average return
Main Sectors:
Stocks Rated by Yuan Zhi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RADX Radiopharm Theranostics | Reiterates: Buy | $13 → $16 | $5.14 | +211.28% | 3 | Dec 16, 2025 | |
| RDNT RadNet | Maintains: Buy | $71 → $87 | $70.93 | +22.66% | 2 | Dec 1, 2025 | |
| TNGX Tango Therapeutics | Maintains: Buy | $8 → $14 | $13.01 | +7.61% | 3 | Nov 18, 2025 | |
| CATX Perspective Therapeutics | Maintains: Buy | $12 → $11 | $2.33 | +372.10% | 4 | Nov 18, 2025 | |
| MIR Mirion Technologies | Reiterates: Buy | $17 → $22 | $26.93 | -18.31% | 3 | Jul 23, 2025 | |
| TOI The Oncology Institute | Initiates: Buy | $6 | $3.35 | +79.10% | 1 | Jul 16, 2025 | |
| HYPR Hyperfine | Maintains: Buy | $1.2 → $1 | $1.20 | -16.67% | 2 | May 15, 2025 | |
| AGEN Agenus | Maintains: Buy | $42 → $18 | $3.34 | +438.92% | 2 | Aug 14, 2024 | |
| CYRX Cryoport | Upgrades: Buy | $19 → $15 | $11.04 | +35.87% | 4 | Jul 31, 2024 | |
| CTSO Cytosorbents | Reiterates: Buy | $3 | $0.70 | +327.35% | 1 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $61 → $79 | $40.00 | +97.50% | 3 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $16 | $1.33 | +1,103.01% | 4 | Dec 11, 2023 |
Radiopharm Theranostics
Dec 16, 2025
Reiterates: Buy
Price Target: $13 → $16
Current: $5.14
Upside: +211.28%
RadNet
Dec 1, 2025
Maintains: Buy
Price Target: $71 → $87
Current: $70.93
Upside: +22.66%
Tango Therapeutics
Nov 18, 2025
Maintains: Buy
Price Target: $8 → $14
Current: $13.01
Upside: +7.61%
Perspective Therapeutics
Nov 18, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $2.33
Upside: +372.10%
Mirion Technologies
Jul 23, 2025
Reiterates: Buy
Price Target: $17 → $22
Current: $26.93
Upside: -18.31%
The Oncology Institute
Jul 16, 2025
Initiates: Buy
Price Target: $6
Current: $3.35
Upside: +79.10%
Hyperfine
May 15, 2025
Maintains: Buy
Price Target: $1.2 → $1
Current: $1.20
Upside: -16.67%
Agenus
Aug 14, 2024
Maintains: Buy
Price Target: $42 → $18
Current: $3.34
Upside: +438.92%
Cryoport
Jul 31, 2024
Upgrades: Buy
Price Target: $19 → $15
Current: $11.04
Upside: +35.87%
Cytosorbents
May 15, 2024
Reiterates: Buy
Price Target: $3
Current: $0.70
Upside: +327.35%
Feb 1, 2024
Maintains: Buy
Price Target: $61 → $79
Current: $40.00
Upside: +97.50%
Dec 11, 2023
Maintains: Buy
Price Target: $20 → $16
Current: $1.33
Upside: +1,103.01%